The American Association of Clinical Endocrinologists (AACE) was founded in 1991 by a visionary group of leaders to serve as the active voice for clinical endocrinologists. Members of AACE are physicians with special education, training, and interest in the practice of clinical endocrinology. These physicians devote a significant part of their career to the evaluation and management of patients with endocrine disease. All members of AACE are physicians (M.D. or D.O.) and a majority is certified by Boards recognized by the American Board of Medical Specialties. Members of AACE are recognized clinicians, educators and scientists, many of whom are affiliated with medical schools and universities.
The mission of the American College of Cardiology (ACC) is to transform cardiovascular care and improve heart health. Beginning in the 1980s, the ACC emerged as a leader in determining quality care when it partnered with the American Heart Association to develop the first clinical practice guidelines. These guidelines took the best science and translated it to everyday practice. In addition to building standards for care, the College was breaking new ground in measuring quality. The ACC strives to achieve its enduring purpose: to improve cardiovascular health through education, research, quality care and health policy.
When the ASPC was founded in 1975, its members were physicians and educators, including frequent recipients of the National Heart, Lung, and Blood Institute (NHLBI) Preventive Cardiology Academic Award (PCAA). The organization's goals were developing programs that enhanced basic and clinical education and initiating or expanding interdisciplinary clinical services and research initiatives in preventive cardiology. The new ASPC will represent the increasingly multidisciplinary group of healthcare providers along with researchers and industry representatives who share an interest in and passion for preventive cardiology.
The ASH was founded in 1985 in order to provide a forum for the exchange of information among basic scientists, clinical investigators and others involved in the study or management of high blood pressure. ASH is the largest organization of hypertension researchers and health care providers in the United States committed to preventing and treating hypertension and its consequences. ASH has a domestic and international membership of basic science & clinical investigators, physicians, physician assistants, nurse practitioners, pharmacists, as well as individuals with a scientific interest in hypertension.
The International Atherosclerosis Society (IAS), incorporated in 1979, promotes, at an international level, the advancement of science, research and teaching in the field of atherosclerosis and related diseases.
PCNA was originally founded as the Lipid Nurse Task Force (LNTF) in 1992 by a small group of California nurses who were concerned about the lack of educational opportunities for nursing professionals specializing in lipid disorders. The Mission of PCNA is to increase public and political awareness of the critical role nurses play in comprehensive cardiovascular risk reduction and promote individual and community education in cardiovascular risk reduction and disease management across the lifespan.
Established by leading researchers as a not-for-profit organisation, the PCSK9 Education and Research Forum will provide healthcare professionals with open access to electronic and multimedia platforms providing real-time reporting of significant developments and news; authoritative analysis and commentary; and, an extensive library of accredited educational materials tailored to the differing needs of a spectrum of audiences. As a result, the Forum will expand awareness and knowledge of the significant role played by PCSK9 in lipid metabolism and its value as a novel therapeutic target.
SCAN is the largest dietetic practice group of the Academy of Nutrition and Dietetics. Members are registered dietitians with nutrition expertise in the areas of sports, physical activity, cardiovascular health, wellness, and the prevention and treatment of disordered eating and eating disorders.Their mission is to empower members to be the nation’s food and nutrition leaders through excellence and expertise in nutrition for sports and physical activity, cardiovascular health, wellness, and disordered eating and eating disorders.
The Residual Risk Reduction initiative (R3i) is a worldwide, academic, multidisciplinary, non-profit, Swiss-law Foundation established by international researchers and clinicians who recognize the importance of the high risk of fatal and non-fatal macro- and micro-vascular complications occurring in patients with atherogenic dyslipidemia who are already receiving the current standards of care. To address this issue, it engages healthcare professionals in an innovative global initiative of academic research, education and advocacy with the goal of significantly improving and extending the lives of millions of patients with heart disease and/or diabetes.
The National Forum for Heart Disease and Stroke Prevention is an independent non-profit, 501(c)(3), voluntary health organization that leads collaborative policy efforts and builds a collective voice for the prevention of heart disease and stroke. The National Forum serves as a catalyst to provide a space and place for multi-sector groups to work together. National Forum membership includes more than 65 national and international organizations representing public and private, health care, advocacy, academic, policy, and community organizations.